Manufacturer record

Sanctus Global Formulations Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Sanctus Global Formulations Limited (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Sanctus Global Formulations Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2023 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2023
4
Products affected
Dissolution
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2023 · 12025 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Metoprolol Tartrate Tablets IP 50mg (Metoder 50) SG25068Mfg 2025-06 · Exp 2027-05 Sample fails the test ' Dissolution' mentioned in the Laboratory Protocol as per IP.Dissolution DTL KonniState lab Feb 2026
Pantoprazole Gastro Reistant and Dompendone Prolonged Release Capsule IP 2307045Mfg 2023-07 · Exp 2025-07 DissolutionDissolution DTL, JaipurState lab Aug 2025
Clopidogrel and Aspirin Tablets IP (AclizacAS 75) 2411039Mfg 2024-11 · Exp 2026-10 The sample does not conform to the IP with respect to Assay of Aspirin & Free Salicylic AcidAssay DTL,Jaipur (StateState lab May 2025
Glimepiride Tablets I.P. (Glimicut-1) SG22022Mfg 2022-03 · Exp 2024-02 DissolutionDissolution RDTL GuwahatiState lab Dec 2023

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.